$2.80
0.051.82%
At close: -
$2.85
0.051.79%
After Hours: Nov 20, 4:02 PM EDT
Comments
Loading...
Relmada Therapeutics (RLMD) Forecast
NewsEarningsRelmada Therapeutics (RLMD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestRelmada Therapeutics (NASDAQ:RLMD) Stock Quotes, Forecast and News Summary
Relmada Therapeutics Stock (NASDAQ: RLMD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Relmada Therapeutics (RLMD) stock?
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
Who are Relmada Therapeutics (RLMD) competitors?
Other companies in Relmada Therapeutics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI) and Nutriband (NASDAQ:NTRB).
What is the forecast, or price target, for Relmada Therapeutics (RLMD) stock?
Relmada Therapeutics has a consensus price target of $20.80.
What is the current price for Relmada Therapeutics (RLMD)?
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $2.85 last updated November 20, 2024 at 4:02 PM EST.
Does Relmada Therapeutics (RLMD) pay a dividend?
There are no upcoming dividends for Relmada Therapeutics.
When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?
Relmada Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Relmada Therapeutics (RLMD) going to split?
There is no upcoming split for Relmada Therapeutics.
What sector and industry does Relmada Therapeutics (RLMD) operate in?
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.